Trial Profile
Efficacy and safety of TAF prophylactic administration for HBV reactivation hepatitis during immunosuppressive or anti-tumor therap
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 Dec 2018 New trial record